KospicyKorean filings in English
Filings / GENOLUTION INC.

Beneficial Ownership Report (5%) — Standard Form

GENOLUTION INC. · 주식등의대량보유상황보고서(일반)

SC 13D/GKOSDAQ · 225220 Filed 2026-11-10Korean original on DART

English form view 78% translated

Translated from a fixed dictionaryLeft in Korean (free text, names)Numbers and dates are copied unchanged

Report on large shareholdings (general)

6.1

(주)제놀루션

0000

Report on Large Holdings of Shares, etc.

(General form: reports under Article 147 of the Financial Investment Services and Capital Markets Act with the purpose of influencing management control)
To: Financial Services CommissionReporting obligation date:2026-11-03
To: Korea ExchangeReport reference date:2026-11-10
Reporting person:김기옥
Summary
Issuer name(주)제놀루션Relationship to IssuerLargest Shareholder
Report TypeChange
Number of Shares Held and Holding RatioNumber of Shares HeldHolding Ratio
Previous Report5,497,92728.65
Current Report5,527,92728.81
Shares under key agreements: number and ratioNumber of shares, etc.Ratio
Previous Report0-
Current Report0-
Number of voting rights and holding ratioNumber of Voting RightsHolding Ratio
Previous Report--
Current Report--
Voting rights under key agreements: number and ratioNumber of Voting RightsRatio
Previous Report--
Current Report--
Reason for ReportOn-market purchase
※ The reporting person confirms that holdings of shares, etc. by the reporting person and specially related parties as of the reference date are accurately stated per applicable laws and filing instructions, with no material misstatement or omission.

Part 1 Report Overview

1. Issuer information

Company Name(주)제놀루션Company code225220
Entity typeKOSDAQ-Listed CompanyTotal Issued Voting Shares (shares)19,190,021

2. Major shareholder information

a. Reporting person

(1) Reporting person overview

Report TypeChangeJoint signatories
Reporting person typeIndividual (Domestic)NationalityRepublic of Korea
Basis for Reporter Classification (only if reported as a statutory partnership or other entity)-
Name (Entity Name)Korean김기옥Chinese characters (English)Kim Gi Ok
Address (Head Office) [Town/District Level Only]서울특별시 강동구 둔촌동Date of Birth or Business Registration No., etc.551002
Occupation (business)CEORelationship to IssuerLargest Shareholder
Business contact and person in chargeAffiliated company(주)제놀루션DepartmentIR Team
PositionGeneral ManagerPhone Number070-41***
Name이대섭Fax number02-643**
Email address**@genolution1.com

(2) Reporting Person Details (for Corporations, Other Organizations, Statutory Associations, or Civil-Law Partnerships)

Legal form-
Total Assets (or Total Assets Under Management)-Total Liabilities-
Total Equity-Paid-in Capital-
Representative (representative or managing partner)-
Decision-Making Body (Decision Maker)-
Largest Shareholder (Largest Investor)-Largest Shareholder Ownership (%) (Largest Investor Contribution Ratio)-

b. Specially related parties

(1) Specially related party overview

No.NameCategorySpecific Relationship to ReporterDate of Birth or Business Registration No., etc.NationalityAddress (Location)Occupation (Business)Relationship to Issuer
1김민이Individual (Domestic)Relatives861116Republic of Korea서울 강서구 양천로제놀루션 대표이사Executive officers (registered)
2김민호Individual (Domestic)Relatives850701Republic of Korea서울시 강남구 삼성로ExecutiveShareholder
3KimSangHoon개인(외국)Relatives600912USA경기도 성남시 이매동제놀루션 임원Executives (unregistered)
4(주)호일바이오메드Domestic corporationAffiliate209-81-13983Republic of Korea서울 송파구 송파대로의료기기 도매업Affiliates, etc.
5EK Health Services IncForeign CorporationAffiliate77-0497964USASTE 101 SAN JOSE.CA95129 USA-Affiliates, etc.
6최영백Individual (Domestic)Relatives810521Republic of Korea서울 강서구 양천로-Shareholder
7김소현Individual (Domestic)Relatives890217Republic of Korea경기도 성남시 분당구 양현로-Shareholder
8김우진Individual (Domestic)Other690715Republic of Korea서울시 강남구 암구정로제놀루션 임원Executives (unregistered)
9신희종Individual (Domestic)Other830523Republic of Korea서울시 구로구 신도림로제놀루션 임원Executives (unregistered)
10이순신Individual (Domestic)Other610328Republic of Korea경기도 의왕시 새롬길21제놀루션 임원Executives (unregistered)
11박정훈Individual (Domestic)Other740706Republic of Korea경기도 화성시 동탄공원로제놀루션 임원Executives (unregistered)
* Address to town/district level only

(2) 특별관계자에 대한 구체적인 사항[진엑스]

Legal formCo., Ltd.
Total Assets (or Total Assets Under Management)40,322Total Liabilities19,976
Total Equity20,346Paid-in Capital600
Representative (representative or managing partner)김민호, 김기옥
Decision-Making Body (Decision Maker)Representative
Largest Shareholder (Largest Investor)김민호Largest Shareholder Ownership (%) (Largest Investor Contribution Ratio)29.2

[EK Health Services Inc, USD]

Legal formCo., Ltd.
Total Assets (or Total Assets Under Management)UD$27,101,459Total LiabilitiesUS$1,614,461
Total EquityUS$25,486,998Paid-in CapitalUS$20,000
Representative (representative or managing partner)Eunhee Kim
Decision-Making Body (Decision Maker)Representative
Largest Shareholder (Largest Investor)Eunhee KimLargest Shareholder Ownership (%) (Largest Investor Contribution Ratio)100.0

c. Collective investment manager

(Only if the reporting person or specially related party is a "collective investment vehicle" under Regulation Art. 3-10(2))

(1) Collective investment manager overview

No.NameBusiness Registration No., etc.Target collective investment vehicleNationalityAddress (Location)Remarks
-------
-------

(2) Collective investment manager details

Legal form-
Paid-in Capital-Total Assets Under Management-
Representative-
Decision-Making Body (Decision Maker)-
Largest Shareholder (Corporate Representative)-Largest Shareholder Stake-

3. Shares, etc. held and holding ratio

Report reference dateReporting personShares, etc.Share CertificatesTotal Issued Voting Shares (shares)
Name of HolderNumber of Specially Related PersonsNumber of Shares, etc. (shares)Ratio (%)Number of Shares (shares)Ratio (%)
Previous Report2026.10.16김기옥115,497,92728.655,497,92728.6519,190,021
This Report2026.11.10김기옥115,527,92728.815,527,92728.8119,190,021
Change30,0000.1630,0000.1619,190,021

4. Purpose of holding

Impact on management control
보고자 본인은 자본시장법과 금융투자업에 관한 법률 시행령 제 154조 제1항 각 호와 같은 경영사항 모두에 대하여 영향력을 행사할 목적으로 주식을 보유하고 있으며, 향후 각각의 경영사항이 발생할 경우 주주 및 회사의 이익을 극대화하는 방향으로 관련 행위들을 결정할 것입니다.※ 자본시장과 금융투자업에 관한 법률 시행령 제 154조 제 1항 각 호1. 이사 및 감사의 선임. 해임 또는 직무의 정지2. 이사회 등 회사의 기관과 관련된 정관의 변경3. 회사의 자본금의 변경4. 회사의 배당금의 결정5. 회사의 합병, 분할 및 분할합병6. 주식의 포괄적 교환 및 이전7. 영업전부의 양수, 양도 또는 금융위원회가 정하여 고시하는 중요한 일부의 양수, 양도8. 자산의 전부의 처분 또는 금융위원회가 정하여 고시하는 중요한 일부의 처분9. 영업전부의 임대 또는 경영위임, 타인과 영업의 손익전부를 같이 하는 계약, 그 밖에 이에 준하는 계약의 체결, 변경 또는 해약10. 회사의 해산 등

5. Reason for change

Method of changeOn-market purchase
Reason for change단순 추가취득
Reason for Change-

Part 2 Details of Large Holdings

1. Holdings by reporting person and specially related persons

A. Holdings by type of shares, etc.

RelationshipNameDate of Birth or Business Registration No., etc.Details of Shares Held
Share certificatesInstruments representing preemptive rightsConvertible bondsBonds with warrantsExchangeable bondsDepositary receiptsOtherTotal
Voting SharesShares Redeemable into Voting SharesShares Convertible into Voting SharesNumber of sharesRatio (%)
Reporting person김기옥5510023,472,360--------3,472,36018.09
Specially Related Party김민이861116728,721--------728,7213.80
KimSangHoon600912408,000--------408,0002.13
김민호850701679,038--------679,0383.54
(주)호일바이오메드209-81-1398330,000--------30,0000.16
EK Health Services Inc77-0497964141,400--------141,4000.74
최영백81052113,368--------13,3680.07
김소현8902174,040--------4,0400.02
김우진69071529,500--------29,5000.15
신희종8305236,500--------6,5000.03
이순신6103285,000--------5,0000.03
박정훈74070610,000--------10,0000.05
Aa1a2BCDEFG
H
Total Issued Voting Shares (I)Number of Potential Shares Held (a1+a2+B+C+D+E+F+G=H)Holding Ratio (%)
Holding Ratio of Shares, etc. [A+H / I+H-(E+F+G)※] × 100Share Holding Ratio (A / I) × 100
19,190,021-28.8128.81

※ Holding ratio calculated excluding from the denominator only exchangeable bonds exchangeable into shares, depositary receipts and derivative-linked securities with shares as underlying, and stock options settled in treasury shares

B. Holdings by form of holding

RelationshipName (Entity Name)Date of Birth or Business Registration No., etc.Type of holding equivalent to ownership (Article 142, Enforcement Decree of the Financial Investment Services and Capital Markets Act)Total
No. 1No. 2No. 3No. 4No. 5No. 6No. 7Number of sharesRatio
Reporting person김기옥5510023,472,360------3,472,36018.09
Specially Related Party김민이861116728,721------728,7213.80
KimSangHoon600912408,000------408,0002.13
김민호850701679,038------679,0383.54
(주)호일바이오메드209-81-1398330,000------30,0000.16
EK Health Services Inc77-0497964141,400------141,4000.74
최영백81052113,368------13,3680.07
김소현8902174,040------4,0400.02
김우진69071529,500------29,5000.15
신희종8305236,500------6,5000.03
이순신6103285,000------5,0000.03
박정훈74070610,000------10,0000.05
※ Holdings equivalent to ownership (Article 142, Enforcement Decree of the Financial Investment Services and Capital Markets Act) - Item 1: owning shares, etc. for one's own account, in whatever name - Item 2: holding a right to claim delivery of shares, etc. under law, a sale, or other contract - Item 3: holding voting rights (including the right to direct voting) over the shares, etc. under law, a money trust, security, or other contract - Item 4: holding the authority to acquire or dispose of the shares, etc. under law, a money trust, security, discretionary investment, or other contract - Item 5: acquiring, through a unilateral reservation for sale of shares, etc., the right to complete the sale, and holding buyer status by exercising that right - Item 6: holding contractual rights under Article 5(1)(2) of the Act with shares, etc. as underlying assets, and holding buyer status by exercising those rights - Item 7: being granted stock options and holding buyer status by exercising them

2. Contracts on shares held

A. Contract status

Execution or amendment of key agreements (trust, collateral, lending, discretionary, OTC trading, joint holding, etc.)
None

*Voting rights on unreported holdings may be restricted if execution/amendment of material contracts is not reported

*2026-10-14 특수관계자간 장외매매계약을 체결하고 당일 거래가 완료되어 공시제출일 현재 계약은 종료되었습니다.

B. Contract details

No.Name (Entity Name)Relationship to ReporterDate of Birth or Business Registration No., etc.Type of shares, etc.Number of shares, etc.CounterpartyContract typeContract date (amendment date)Contract periodRatioRemarks
------------
Total (number of shares, etc.)0Total (ratio)--

C. Additional details if the main contract is a security agreement

No.Number of shares, etc.Loan amountDebtorInterest rateCollateral maintenance ratioOther
-------
-------

3. Holdings by proprietary and customer account (financial institutions only)

NameRelationship to ReporterBy accountTotal
Own Account (shares)Ratio (%)Customer account (shares)Ratio (%)Total (shares)Ratio (%)
--------
--------
Total------

Part 3 Material Changes Since Last Report Date

1. Summary of changes

a. Changes in shares, etc.

RelationshipNameDate of Birth or Business Registration No., etc.Details of Changes in Shares, etc.
Share certificatesInstruments representing preemptive rightsConvertible bondsBonds with warrantsExchangeable bondsDepositary receiptsOtherTotal
Voting SharesShares Redeemable into Voting SharesShares Convertible into Voting SharesNumber of sharesRatio (%)
Reporting person-------------
Specially Related Party(주)호일바이오메드209-81-1398330,000--------30,0000.16
-------------

2. Change details

a. Detailed changes in shares, etc.

(Unit: shares, KRW)
Name (Entity Name)Date of Birth or Business Registration No., etc.Change Date*Acquisition/disposal methodType of shares, etc.Change detailsAcquisition/disposal unit price**Remarks
Before ChangeChangeAfter Change
(주)호일바이오메드209-81-139832026.11.03On-Market Purchase (+)Voting Shares027271,710--
(주)호일바이오메드209-81-139832026.11.04On-Market Purchase (+)Voting Shares278,9739,0001,749--
(주)호일바이오메드209-81-139832026.11.05On-Market Purchase (+)Voting Shares9,0003,00012,0001,723--
(주)호일바이오메드209-81-139832026.11.06On-Market Purchase (+)Voting Shares12,0002,00014,0001,709--
(주)호일바이오메드209-81-139832026.11.09On-Market Purchase (+)Voting Shares14,0006,00020,0001,719--
(주)호일바이오메드209-81-139832026.11.10On-Market Purchase (+)Voting Shares20,00010,00030,0001,731--

* For trades on the securities market, the contract date

** For securities other than shares, the exercise (conversion/exchange) price of the securities or the unit price of shares acquired/disposed of through exercise of rights; amounts in ( ) are the unit price of the securities

3. Source of acquisition funds

(1) Overview of acquisition funds

(Unit: KRW)
NameDate of birth or business registration no., etc.Own funds (H)Borrowings (I)Other (J)Total (H+I+J)
(주)호일바이오메드209-81-1398351,959,398--51,959,398

(2) Origin and source of acquisition funds

ㅇ If own funds

NameDate of birth or business registration no., etc.Source and Formation of Acquisition Funds
(주)호일바이오메드209-81-13983사업 소득